Endometriosis is an estrogen-driven, inflammatory disorder affecting ~10% of menstruators, causing severe pain. Current treatments that reduce estrogen or inflammation have inconsistent efficacy and poor tolerability. Therapies identified via drug-repositioning …
Oral Wnt-blocking pill plus lenvatinib shows promise in endometrial cancer after immunotherapy fails Bioengineer.org
Oral Wnt-blocking pill plus lenvatinib shows promise in endometrial cancer after immunotherapy fails bioengineer.org
Transdermal MHT a potentially safer alternative to oral options Medical Republic
Transdermal MHT a potentially safer alternative to oral options medicalrepublic.com.au
Traditional behavioral finance-which examines how cognitive biases, emotions, and context shape economic decision-making- often assumes cognitive stability, rationality, and consistent risk evaluation, based largely on male-dominated samples. Emerging evidence from …
Endometriosis is a chronic gynecological disorder characterized by persistent pain and impaired quality of life, with limited effective treatment options. Emerging evidence indicates that cannabinoids may provide analgesic and symptom-relieving …
Objectives. The aim of the study was to develop a diagnostic method for estrogen hypersensitivity syndrome in proliferative benign diseases of the female reproductive system. Using the example of endometriosis, …
Epithelial ovarian cancer is not a single disease but a group of biologically distinct malignancies that include serous (high-grade and low-grade), endometrioid, clear cell, and mucinous carcinomas, along with other …
FTH: Oral multi-node PAM pathway inhibition advances with pivotal data expected in endometrial cancer TradingView